Market Research Life Sciences Market Research Medical Devices Market Research Cardiovascular Devices Market Research

Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2020

Best Price Guarantee Length Publisher Published Date SKU
from $4,000 241 Pages GlobalData October, 2020 GBDT16415169
Best Price Guarantee
Price from $4,000
Length 241 Pages
Publisher GlobalData
Published Date October, 2020
SKU GBDT16415169

Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2020 provides comprehensive information about the Transcatheter Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter Heart Valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Transcatheter Heart Valves Overview
  • Products under Development
    • Transcatheter Heart Valves - Pipeline Products by Stage of Development
      • Table Figure 1: Transcatheter Heart Valves - Pipeline Products by Stage of Development
      • Table Transcatheter Heart Valves - Pipeline Products by Stage of Development
    • Transcatheter Heart Valves - Pipeline Products by Segment
      • Table Figure 2: Transcatheter Heart Valves - Pipeline Products by Segment
      • Table Transcatheter Heart Valves - Pipeline Products by Segment
    • Transcatheter Heart Valves - Pipeline Products by Territory
      • Table Figure 3: Transcatheter Heart Valves - Pipeline Products by Territory
      • Table Transcatheter Heart Valves - Pipeline Products by Territory
    • Transcatheter Heart Valves - Pipeline Products by Regulatory Path
      • Table Figure 4: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
      • Table Transcatheter Heart Valves - Pipeline Products by Regulatory Path
    • Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
      • Table Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
    • Transcatheter Heart Valves - Ongoing Clinical Trials
      • Table Figure 6: Transcatheter Heart Valves - Ongoing Clinical Trials
      • Table Transcatheter Heart Valves - Ongoing Clinical Trials
  • Transcatheter Heart Valves - Pipeline Products under Development by Companies
    • Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
      • Table Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
    • Transcatheter Heart Valves – Companies Pipeline Products by Stage of Development
      • Table Transcatheter Heart Valves – Companies Pipeline Products by Stage of Development
  • Transcatheter Heart Valves Companies and Product Overview
    • 3DT Holdings LLC Company Overview
      • 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tissue Heart Valve - Product Status
        • Table Tissue Heart Valve - Product Description
    • 4C Medical Technologies Inc Company Overview
      • 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AltaValve - Product Status
        • Table AltaValve - Product Description
        • Table 4C Medical Technologies Inc - Ongoing Clinical Trials Overview
        • Table AltaValve - AltaValve Early Feasibility Study Protocol
    • Aegis Surgical Limited Company Overview
      • Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table pTAo-TAVR - Product Status
        • Table pTAo-TAVR - Product Description
    • Anchorvalve Company Overview
      • Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status
        • Table Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description
        • Table Sutureless Trans-Catheter Tricuspid Valve Replacement (TTVR) - Product Status
        • Table Sutureless Trans-Catheter Tricuspid Valve Replacement (TTVR) - Product Description
    • Annulon Company Overview
      • Annulon Pipeline Products & Ongoing Clinical Trials Overview
        • Table Annulon Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mitral Valve Replacement Device - Product Status(Annulon)
        • Table Mitral Valve Replacement Device - Product Description(Annulon)
    • Anteris Technologies Ltd Company Overview
      • Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DurAVR Heart Valve - Product Status
        • Table DurAVR Heart Valve - Product Description
        • Table Anteris Technologies Ltd - Ongoing Clinical Trials Overview
        • Table DurAVR Heart Valve - First in Human Surgical Implantation of Single Piece ADAPT Treated 3D ALR (Aortic Leaflet Repair), Feasibility and Clinical Safety Study
    • AorTx, Inc. Company Overview
      • AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AorTx Valve - Product Status
        • Table AorTx Valve - Product Description
    • Arbor Surgical Technologies, Inc. Company Overview
      • Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trilogy Aortic Valve System - Product Status
        • Table Trilogy Aortic Valve System - Product Description
    • Boston Children's Hospital Company Overview
      • Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pulmonary Valve Replacement Device - Product Status
        • Table Pulmonary Valve Replacement Device - Product Description
        • Table Two Piece Replacement Heart Valve - Product Status
        • Table Two Piece Replacement Heart Valve - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gen 4 Lotus Valve System - Product Status
        • Table Gen 4 Lotus Valve System - Product Description
        • Table Lotus Edge Sheath 15F - Product Status
        • Table Lotus Edge Sheath 15F - Product Description
        • Table LOTUS Edge Valve Expanded Sizes - Product Status
        • Table LOTUS Edge Valve Expanded Sizes - Product Description
        • Table LOTUS Mantra - Product Status
        • Table LOTUS Mantra - Product Description
        • Table Lotus Valve System - 21 mm - Product Status
        • Table Lotus Valve System - 21 mm - Product Description
        • Table Lotus Valve System - 23 mm - Product Status
        • Table Lotus Valve System - 23 mm - Product Description
        • Table Lotus Valve System - 25 mm - Product Status
        • Table Lotus Valve System - 25 mm - Product Description
        • Table Lotus Valve System - 27 mm - Product Status
        • Table Lotus Valve System - 27 mm - Product Description
        • Table Lotus Valve System - 29 mm - Product Status
        • Table Lotus Valve System - 29 mm - Product Description
        • Table Transaortic Sheath - Product Status
        • Table Transaortic Sheath - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table Lotus Valve System - 23 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
        • Table Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
        • Table Lotus Valve System - 23 mm - REPRISE China: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Edge Valve System - Clinical Evaluation in China
        • Table Lotus Valve System - 23 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 27 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
        • Table Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
        • Table Lotus Valve System - 27 mm - REPRISE China: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Edge Valve System - Clinical Evaluation in China
        • Table Lotus Valve System - 27 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 25 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
        • Table Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
        • Table Lotus Valve System - 25 mm - REPRISE China: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Edge Valve System - Clinical Evaluation in China
        • Table Lotus Valve System - 25 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 21 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 21 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
        • Table Lotus Valve System - 21 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
        • Table Lotus Valve System - 29 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
        • Table Lotus Valve System - 29 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Randomized Clinical Evaluation: REPRISE III
        • Table Lotus Valve System - 29 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
    • Cardiovalve Ltd Company Overview
      • Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiovalve Transfemoral Mitral Valve System - Product Status
        • Table Cardiovalve Transfemoral Mitral Valve System - Product Description
        • Table Cardiovalve Ltd - Ongoing Clinical Trials Overview
        • Table Cardiovalve Transfemoral Mitral Valve System - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation
        • Table Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
        • Table Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
        • Table Cardiovalve Transfemoral Mitral Valve System - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study
    • Carena Healthcare Ltd Company Overview
      • Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PILLAR 3D Printed Replacement Heart Valve - Product Status
        • Table PILLAR 3D Printed Replacement Heart Valve - Product Description
    • Cephea Valve Technologies, Inc. Company Overview
      • Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mitral Valve Replacement Device - Product Status
        • Table Mitral Valve Replacement Device - Product Description
    • Clemson University Company Overview
      • Clemson University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clemson University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Bioprosthetic Heart Valve - Product Status
        • Table Transcatheter Bioprosthetic Heart Valve - Product Description
    • Colibri Heart Valve LLC Company Overview
      • Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colibri Aortic Heart Valve - 21mm - Product Status
        • Table Colibri Aortic Heart Valve - 21mm - Product Description
        • Table Colibri TAVI System - Product Status
        • Table Colibri TAVI System - Product Description
        • Table Delta Aortic Heart Valve - Product Status
        • Table Delta Aortic Heart Valve - Product Description
        • Table Mitral Valve - Product Status
        • Table Mitral Valve - Product Description
        • Table Second-Generation TAVI System - Product Status
        • Table Second-Generation TAVI System - Product Description
        • Table Venibri Transcatheter Heart Valve System - Product Status
        • Table Venibri Transcatheter Heart Valve System - Product Description
        • Table Colibri Heart Valve LLC - Ongoing Clinical Trials Overview
        • Table Colibri TAVI System - A Prospective, Single Arm Clinical Investigation Evaluating Safety and Performance of the Colibri Transcatheter Aortic Heart Valve System for the Treatment of Symptomatic Severe Aortic Stenosis Via Transfemoral Access in High Surgical Risk Patients
    • Daidalos Solutions BV Company Overview
      • Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) - Product Status
        • Table Sutureless Trans-Catheter Aortic Valve Replacement (TAVR) - Product Description
    • Direct Flow Medical Inc (Inactive) Company Overview
      • Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Status
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - Product Description
        • Table 22F Percutaneous Aortic Valve System - Product Status
        • Table 22F Percutaneous Aortic Valve System - Product Description
        • Table Direct Flow Medical Transcatheter Mitral Valve - Product Status
        • Table Direct Flow Medical Transcatheter Mitral Valve - Product Description
        • Table Direct Flow Medical Inc (Inactive) - Ongoing Clinical Trials Overview
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - A Registry to Evaluate the Direct Flow Medical Transcatheter Aortic Valve System for the Treatment of Patients with Severe Aortic Stenosis
        • Table 18F Direct Flow Medical Transcatheter Aortic Valve System - SALUS Trial Transcatheter Aortic Valve Replacement System Pivotal Trial the Safety and Effectiveness of the Direct Flow Medical Tanscatheter Aortic Valve System
    • DSM Dyneema BV Company Overview
      • DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dyneema Purity - Transcatheter Heart Valve - Product Status
        • Table Dyneema Purity - Transcatheter Heart Valve - Product Description
    • Dura LLC Company Overview
      • Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Joyce Fit TPVR System - Product Status
        • Table Joyce Fit TPVR System - Product Description
        • Table LowPro Valve - Product Status
        • Table LowPro Valve - Product Description
        • Table Sutra TMVR System - Product Status
        • Table Sutra TMVR System - Product Description
    • Edwards Lifesciences Corp Company Overview
      • Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table CardiAQ Mitral Valve - Product Status
        • Table CardiAQ Mitral Valve - Product Description
        • Table EVOQUE Mitral Valve Replacement Device - Product Status
        • Table EVOQUE Mitral Valve Replacement Device - Product Description
        • Table EVOQUE Tricuspid Valve Replacement System - Product Status
        • Table EVOQUE Tricuspid Valve Replacement System - Product Description
        • Table FORTIS Mitral Transcatheter Heart Valve - Product Status
        • Table FORTIS Mitral Transcatheter Heart Valve - Product Description
        • Table Next Gen CENTERA - Product Status
        • Table Next Gen CENTERA - Product Description
        • Table PASCAL Transcatheter Mitral Valve Repair System - DMR - Product Status
        • Table PASCAL Transcatheter Mitral Valve Repair System - DMR - Product Description
        • Table Sapien 3 Heart Valve - Heart Failure - Product Status
        • Table Sapien 3 Heart Valve - Heart Failure - Product Description
        • Table SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis - Product Status
        • Table SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis - Product Description
        • Table Sapien Evolutionary Transcatheter Heart Valve - Product Status
        • Table Sapien Evolutionary Transcatheter Heart Valve - Product Description
        • Table Sapien M3 - Product Status
        • Table Sapien M3 - Product Description
        • Table Sapien Revolutionary Transcatheter Heart Valve - Product Status
        • Table Sapien Revolutionary Transcatheter Heart Valve - Product Description
        • Table Sapien X4 - Product Status
        • Table Sapien X4 - Product Description
        • Table Second Generation Transapical Transcatheter Mitral Valve - Product Status
        • Table Second Generation Transapical Transcatheter Mitral Valve - Product Description
        • Table Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
        • Table FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
        • Table CardiAQ Mitral Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
        • Table Sapien M3 - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study
        • Table Sapien M3 - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with Novaflex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery
        • Table Sapien 3 Heart Valve - Heart Failure - Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advanced Heart Failure: A Randomized Trial (TAVR UNLOAD)
        • Table PASCAL Transcatheter Mitral Valve Repair System - DMR - Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients with Mitral Regurgitation
        • Table PASCAL Transcatheter Mitral Valve Repair System - DMR - European Registry of Transcatheter Repair for Secondary Mitral Regurgitation
        • Table PASCAL Transcatheter Mitral Valve Repair System - DMR - Prospective Analysis of the Feasibility of the PASCAL Spacer Technology for Transcatheter Mitral Valve Repair in an All-comers Cohort
        • Table PASCAL Transcatheter Mitral Valve Repair System - DMR - The CLASP Study Edwards PASCAL TranScatheter Mitral Valve Repair System Study
        • Table EVOQUE Mitral Valve Replacement Device - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
        • Table SAPIEN 3 THV - Asymptomatic Severe Aortic Stenosis - Evaluation of Transcatheter Aortic Valve Replacement Compared to Surveillance for Patients with Asymptomatic Severe Aortic Stenosis
        • Table EVOQUE Tricuspid Valve Replacement System - Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
        • Table EVOQUE Tricuspid Valve Replacement System - Edwards Transcatheter Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy Using a Novel Device
    • Emory University Company Overview
      • Emory University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emory University Pipeline Products & Ongoing Clinical Trials Overview
        • Table MitraCath - Product Status
        • Table MitraCath - Product Description
    • Endoluminal Technology Research LLC Company Overview
      • Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Balloon Expandable Paniagua Heart Valve - Product Status
        • Table Balloon Expandable Paniagua Heart Valve - Product Description
    • Florida International University Company Overview
      • Florida International University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Florida International University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Percutaneous Aortic Heart Valve - Product Status
        • Table Percutaneous Aortic Heart Valve - Product Description
    • Foldax Inc Company Overview
      • Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Foldax Mitral Valve - Product Status
        • Table Foldax Mitral Valve - Product Description
        • Table Tria Surgical Aortic Heart Valve - Product Status
        • Table Tria Surgical Aortic Heart Valve - Product Description
        • Table Foldax Inc - Ongoing Clinical Trials Overview
        • Table Tria Surgical Aortic Heart Valve - Early Feasibility Study for the Foldax Tria Aortic Heart Valve
    • HighLife SAS Company Overview
      • HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table HighLife Transcatheter Mitral Valve Replacement System - Product Status
        • Table HighLife Transcatheter Mitral Valve Replacement System - Product Description
        • Table HighLife SAS - Ongoing Clinical Trials Overview
        • Table HighLife Transcatheter Mitral Valve Replacement System - An Early Feasibility Study of the HighLife 28mm Trans-septal Transcatheter Mitral Valve Replacement System
        • Table HighLife Transcatheter Mitral Valve Replacement System - Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients with Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
        • Table HighLife Transcatheter Mitral Valve Replacement System - HighLife Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk
    • HLT, Inc. Company Overview
      • HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meridian Valve - Product Status
        • Table Meridian Valve - Product Description
        • Table HLT, Inc. - Ongoing Clinical Trials Overview
        • Table Meridian Valve - Transfemoral Replacement of Aortic Valve with HLT Meridian Valve Early Feasibility Trial
        • Table Meridian Valve - Transfemoral Replacement of Aortic Valve with HLT Meridian Valve Feasibility Trial Canada
    • JC Medical, Inc. Company Overview
      • JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table J-Valve TAVI System - Transapical - Product Status
        • Table J-Valve TAVI System - Transapical - Product Description
        • Table J-Valve TAVI System - Transfemoral - Product Status
        • Table J-Valve TAVI System - Transfemoral - Product Description
        • Table JC Medical, Inc. - Ongoing Clinical Trials Overview
        • Table J-Valve TAVI System - Transapical - Efficacy and Safety Evaluation for the Interventional Aortic Valve Bioprosthesis and Delivery System in Patients with Severe Aortic Stenosis and/or Aortic Regurgitation with Elevated Surgical Risk
        • Table J-Valve TAVI System - Transfemoral - J-Valve Compassionate Use Cases
    • JenaValve Technology GmbH Company Overview
      • JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table JenaValve Pericardial TAVR System - Product Status
        • Table JenaValve Pericardial TAVR System - Product Description
        • Table JenaValve Technology GmbH - Ongoing Clinical Trials Overview
        • Table JenaValve Pericardial TAVR System - A Study to Assess Safety and Probable Benefit of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of High Surgical Risk Patients with Symptomatic, Severe Aortic Regurgitation (AR)
        • Table JenaValve Pericardial TAVR System - THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Regurgitation (AR)
        • Table JenaValve Pericardial TAVR System - THE ALIGN-AS TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Stenosis (AS)
    • LivaNova PLC Company Overview
      • LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Caisson TMVR System - Product Status
        • Table Caisson TMVR System - Product Description
        • Table LivaNova PLC - Ongoing Clinical Trials Overview
        • Table Caisson TMVR System - Clinical Investigation of the Caisson Transcatheter Mitral Valve Replacement (TMVR) System for Percutaneous Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation
        • Table Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE)
    • Mayo Clinic Company Overview
      • Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
        • Table Percutaneous Aortic Valve - Product Status
        • Table Percutaneous Aortic Valve - Product Description
    • Medtronic Plc Company Overview
      • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CoreValve Evolut PRO - 34 mm - Product Status
        • Table CoreValve Evolut PRO - 34 mm - Product Description
        • Table Evolut FX - Product Status
        • Table Evolut FX - Product Description
        • Table Evolut Next Gen - Product Status
        • Table Evolut Next Gen - Product Description
        • Table Harmony Transcatheter Pulmonary Valve - Product Status
        • Table Harmony Transcatheter Pulmonary Valve - Product Description
        • Table Intrepid Transcatheter Mitral Valve Replacement - Product Status
        • Table Intrepid Transcatheter Mitral Valve Replacement - Product Description
        • Table Intrepid Transcatheter Tricuspid Valve Replacement - Product Status
        • Table Intrepid Transcatheter Tricuspid Valve Replacement - Product Description
        • Table Native Outflow Tract Transcatheter Pulmonary Valve - Product Status
        • Table Native Outflow Tract Transcatheter Pulmonary Valve - Product Description
        • Table Next Generation TCV - Product Status
        • Table Next Generation TCV - Product Description
        • Table Twelve Transcatheter Mitral Valve Replacement System - Product Status
        • Table Twelve Transcatheter Mitral Valve Replacement System - Product Description
        • Table Medtronic Plc - Ongoing Clinical Trials Overview
        • Table Twelve Transcatheter Mitral Valve Replacement System - Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
        • Table Intrepid Transcatheter Mitral Valve Replacement - An Early Feasibility Study of Intrepid Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
        • Table Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in Patients with Severe Symptomatic Mitral Regurgitation - APOLLO Trial
        • Table Harmony Transcatheter Pulmonary Valve - The Medtronic Harmony Transcatheter Pulmonary Valve Clinical Study
        • Table Intrepid Transcatheter Tricuspid Valve Replacement - The Early Feasibility Study of the Transcatheter Tricuspid Valve Replacement System Transfemoral System
    • Micro Interventional Devices, Inc. Company Overview
      • Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endovalve - Transcatheter Mitral Valve Replacement System - Product Status
        • Table Endovalve - Transcatheter Mitral Valve Replacement System - Product Description
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vitaflow II Transcatheter Aortic Valve - Product Status
        • Table Vitaflow II Transcatheter Aortic Valve - Product Description
        • Table MicroPort Scientific Corp - Ongoing Clinical Trials Overview
        • Table Vitaflow II Transcatheter Aortic Valve - A Prospective, Multicenter, Single-arm, Objective Performance Clinical Investigation For Evaluation of the Safety and Effectiveness of MicroPort CardioFlow VitaFlow II Transcatheter Aortic Valve System in the Treatment of Severe Aortic Valve Stenosis
        • Table Vitaflow II Transcatheter Aortic Valve - Evaluating Safety and Effectiveness/Performance of the Microport CardioFlow VitaFlow II - Transcatheter Aortic Valve System: The VITALE Study
    • MitrAssist Ltd. Company Overview
      • MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MitrAssist Valve - Product Status
        • Table MitrAssist Valve - Product Description
    • MValve Technologies Ltd. Company Overview
      • MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table MValve Docking System - Product Status
        • Table MValve Docking System - Product Description
    • NaviGate Cardiac Structures, Inc. Company Overview
      • NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gate Tricuspid Valved Stent - Product Status
        • Table Gate Tricuspid Valved Stent - Product Description
        • Table Navi Mitral Valved Stent - Product Status
        • Table Navi Mitral Valved Stent - Product Description
        • Table NaviGate Cardiac Structures, Inc. - Ongoing Clinical Trials Overview
        • Table Gate Tricuspid Valved Stent - An Early Feasibility Study to Evaluate the Safety and Efficacy of GATE System in Patients with Functional Tricuspid Valve Regurgitation
    • Neovasc Inc Company Overview
      • Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tiara - TF/TS System - Product Status
        • Table Tiara - TF/TS System - Product Description
        • Table Tiara TA Transapical Mitral Valve - Product Status
        • Table Tiara TA Transapical Mitral Valve - Product Description
        • Table Neovasc Inc - Ongoing Clinical Trials Overview
        • Table Tiara TA Transapical Mitral Valve - Early Feasibility Study of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System
        • Table Tiara TA Transapical Mitral Valve - Tiara Transcatheter Mitral Valve Replacement Study (TIARA-II)
    • NewMed Medical Co Ltd Company Overview
      • NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mi-thos TMVR System - Transventricular Septal Approach - Product Status
        • Table Mi-thos TMVR System - Transventricular Septal Approach - Product Description
        • Table Mi-thos Transcatheter Mitral Valve Replacement System - Product Status
        • Table Mi-thos Transcatheter Mitral Valve Replacement System - Product Description
        • Table NewMed Medical Co Ltd - Ongoing Clinical Trials Overview
        • Table Mi-thos Transcatheter Mitral Valve Replacement System - Evaluation of the Efficacy and Safety of the Mi-thos Transcatheter Mitral Valve Replacement System in Patients with Severe Mitral Valve Disease at High Surgical Risk
    • Ningbo Jenscare Biotechnology Co Ltd Company Overview
      • Ningbo Jenscare Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ningbo Jenscare Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table LuX Right-Atrial Tricuspid Valve Replacement System - Product Status
        • Table LuX Right-Atrial Tricuspid Valve Replacement System - Product Description
        • Table LuX Transjugular Tricuspid Valve Replacement System - Product Status
        • Table LuX Transjugular Tricuspid Valve Replacement System - Product Description
        • Table Ningbo Jenscare Biotechnology Co Ltd - Ongoing Clinical Trials Overview
        • Table LuX Right-Atrial Tricuspid Valve Replacement System - The Travel Trial: Transcatheter Right Atrial-ventricular Valve replacement with LuX-valve
    • NVT AG Company Overview
      • NVT AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table NVT AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table ALLEGRA Transfemoral TAVI System - Product Status
        • Table ALLEGRA Transfemoral TAVI System - Product Description
        • Table NVT AG - Ongoing Clinical Trials Overview
        • Table ALLEGRA Transfemoral TAVI System - Clinical Outcomes of the NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population with Elevated Surgical Risk
    • P+F Products + Features GmbH Company Overview
      • P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Mitral Balloon-Expandable Valve - Product Status
        • Table Transcatheter Mitral Balloon-Expandable Valve - Product Description
        • Table Transcatheter Pulmonary Self-Expandable Valve - Product Status
        • Table Transcatheter Pulmonary Self-Expandable Valve - Product Description
        • Table TricValve Transcatheter Bicaval Valves System - Product Status
        • Table TricValve Transcatheter Bicaval Valves System - Product Description
        • Table Vienna Aortic Balloon-Expandable Transcatheter Valve - Product Status
        • Table Vienna Aortic Balloon-Expandable Transcatheter Valve - Product Description
        • Table P+F Products + Features GmbH - Ongoing Clinical Trials Overview
        • Table TricValve Transcatheter Bicaval Valves System - Safety and Efficacy of the TricValve Transcatheter Bicaval Valves System in the Superior and Inferior Vena Cava in Patients with Severe Tricuspid Regurgitation: TRICUS STUDY EURO
    • Peca Labs Inc Company Overview
      • Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fully Synthetic Transcatheter Valve - Product Status
        • Table Fully Synthetic Transcatheter Valve - Product Description
    • Peijia Medical Ltd Company Overview
      • Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Taurus Elite - Product Status
        • Table Taurus Elite - Product Description
        • Table TaurusOne - Product Status
        • Table TaurusOne - Product Description
    • Polares Medical SA Company Overview
      • Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trans-Catheter Mitral Valve Hemi-Replacement System - Product Status
        • Table Trans-Catheter Mitral Valve Hemi-Replacement System - Product Description
    • PolyNova Cardiovascular Inc Company Overview
      • PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trileaflet Polymeric Prosthetic Heart Valve - Product Status
        • Table Trileaflet Polymeric Prosthetic Heart Valve - Product Description
    • Polyvascular Corp Company Overview
      • Polyvascular Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polyvascular Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pediatric Valve Device - Product Status
        • Table Pediatric Valve Device - Product Description
    • RegenaGraft Company Overview
      • RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview
        • Table Synthetic Heart Valve - Product Status
        • Table Synthetic Heart Valve - Product Description
    • ReValve Med Inc Company Overview
      • ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Removable Transcatheter Aortic Valve - Product Status
        • Table Removable Transcatheter Aortic Valve - Product Description
    • RUA Life Sciences Plc Company Overview
      • RUA Life Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RUA Life Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AorTech Polymer Valve - Product Status
        • Table AorTech Polymer Valve - Product Description
    • SAS Cormove Company Overview
      • SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview
        • Table CORMOVE Percutaneous Aortic Valve - Product Status
        • Table CORMOVE Percutaneous Aortic Valve - Product Description
    • Sino Medical Sciences Technology Inc Company Overview
      • Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AccuFit Transapical Mitral Valve Replacement Device - Product Status
        • Table AccuFit Transapical Mitral Valve Replacement Device - Product Description
    • St. Jude Medical LLC Company Overview
      • St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Product Status
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Product Description
        • Table St. Jude Medical LLC - Ongoing Clinical Trials Overview
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Assessment of the Abbott FlexNav Delivery System for Portico Transcatheter Aortic Valve Implantation in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
        • Table Portico Next Generation Transcatheter Aortic Heart Valve - Evaluation of the Portico NG (Next Generation) Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
    • Stony Brook University Company Overview
      • Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation TAVR Valve - Product Status
        • Table Next Generation TAVR Valve - Product Description
    • Symetis SA Company Overview
      • Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Symetis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACURATE neo Aortic Bioprosthesis - Product Status
        • Table ACURATE neo Aortic Bioprosthesis - Product Description
        • Table ACURATE neo2 Transfemoral TAVR System - Product Status
        • Table ACURATE neo2 Transfemoral TAVR System - Product Description
        • Table ACURATE Prime - Product Status
        • Table ACURATE Prime - Product Description
        • Table ACURATE TAo - Product Status
        • Table ACURATE TAo - Product Description
        • Table NG ACURATE - Product Status
        • Table NG ACURATE - Product Description
        • Table Symetis SA - Ongoing Clinical Trials Overview
        • Table ACURATE neo Aortic Bioprosthesis - Acurate Neo Aortic Bioprosthesis for Implantation Using the Acurate Neo TA Transapical Delivery System in Patients with Severe Aortic Stenosis
        • Table ACURATE neo Aortic Bioprosthesis - ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neo AS TF Transfemoral Delivery System in Patients with Severe Aortic Stenosis
        • Table ACURATE neo Aortic Bioprosthesis - Project to Look for Early Discharge in Patients Undergoing TAVI With ACURATE - An International Multi-center Early Discharge TAVI Program
        • Table ACURATE neo Aortic Bioprosthesis - Prospective Evaluation Complementing Investigation with Acurate Neo Device
        • Table ACURATE neo Aortic Bioprosthesis - Prospective, Randomized, Cost-utility Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Brazil
        • Table ACURATE neo Aortic Bioprosthesis - Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis for Transcatheter Aortic Valve Implantation by Transfemoral Approach
        • Table ACURATE neo2 Transfemoral TAVR System - ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects Indicated for TAVR
        • Table ACURATE neo2 Transfemoral TAVR System - ACURATE Neo AS Aortic Bioprosthesis for Implantation Using the ACURATE neo AS TF Transfemoral Delivery System in Patients with Severe Aortic Stenosis
    • The University of British Columbia Company Overview
      • The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
        • Table The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomaterial Heart Valve - Product Status
        • Table Biomaterial Heart Valve - Product Description
    • Thubrikar Aortic Valve, Inc. Company Overview
      • Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Optimum TAVI System - Product Status
        • Table Optimum TAVI System - Product Description
        • Table Thubrikar Aortic Valve, Inc. - Ongoing Clinical Trials Overview
        • Table Optimum TAVI System - A First-in-human Study to Access Feasibility and Safety of the Optimum Aortic Valve Implant
        • Table Optimum TAVI System - Efficacy and Safety of Optimum TAVI System in Subjects with Severe Aortic Stenosis: A First-in-Human Study
    • Trinity College Dublin Company Overview
      • Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
        • Table MiVaR Device - Product Status
        • Table MiVaR Device - Product Description
    • Trisol Medical Ltd Company Overview
      • Trisol Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Trisol Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prosthetic Percutaneous Tricuspid Valve - Product Status
        • Table Prosthetic Percutaneous Tricuspid Valve - Product Description
    • University College London Company Overview
      • University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table University College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gemini Transcatheter Mitral valve - Product Status
        • Table Gemini Transcatheter Mitral valve - Product Description
        • Table TRISKELE Aortic Valve - Product Status
        • Table TRISKELE Aortic Valve - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Valve - Product Status
        • Table Transcatheter Aortic Valve - Product Description
    • University of Cambridge Company Overview
      • University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table Removable Transcatheter Valve - Product Status
        • Table Removable Transcatheter Valve - Product Description
    • University of Iowa Company Overview
      • University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellulose Based Aortic Heart Valve - Product Status
        • Table Cellulose Based Aortic Heart Valve - Product Description
    • Vascudyne Inc Company Overview
      • Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter-Delivered Valve - Product Status
        • Table Transcatheter-Delivered Valve - Product Description
    • Vascular Concepts Ltd Company Overview
      • Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table TAVI (Transcatheter Aortic Valve Replacement) - Product Status
        • Table TAVI (Transcatheter Aortic Valve Replacement) - Product Description
    • Venus MedTech Company Overview
      • Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
        • Table Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transapical Trinity Aortic Valve Implantation System - Product Status
        • Table Transapical Trinity Aortic Valve Implantation System - Product Description
        • Table Transcatheter Mitral Valve Replacement Device - Product Status
        • Table Transcatheter Mitral Valve Replacement Device - Product Description
        • Table Transcatheter Tricuspid Valve Replacement Device - Product Status
        • Table Transcatheter Tricuspid Valve Replacement Device - Product Description
        • Table Transfemoral Trinity Aortic Valve Implantation System - Product Status
        • Table Transfemoral Trinity Aortic Valve Implantation System - Product Description
        • Table Tresillo System - Product Status
        • Table Tresillo System - Product Description
        • Table Venus P-Valve - Product Status
        • Table Venus P-Valve - Product Description
        • Table Venus MedTech - Ongoing Clinical Trials Overview
        • Table Venus P-Valve - Implantation of the Venus P-Valve in the Pulmonic Position in Patients with Native Outflow Tracts
    • Xeltis AG Company Overview
      • Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transcatheter Aortic Heart Valve - Product Status
        • Table Transcatheter Aortic Heart Valve - Product Description
  • Transcatheter Heart Valves- Recent Developments
    • Aug 13, 2020: Neovasc provides corporate update
    • Jun 24, 2020: Apollo Hospitals, Indore successfully performs Transcatheter Aortic Valve Replacement surgery on a nonagenarian patient.
    • Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical
    • Jun 08, 2020: AorTech International : Update on elective surgery and customer orders
    • May 26, 2020: Neovasc provides corporate update
    • May 19, 2020: Anti-calcification comparison study
    • May 15, 2020: Microport orthopedics group brings in new strategic investors
    • May 04, 2020: Venus Medtech and Opus Medical partner for TMVR and TTVR in China
    • May 02, 2020: Venus Medtech and Opus Medical Therapies announce partnership for transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve replacement (TTVR) in greater China market
    • Apr 15, 2020: AorTech International: Further Update re COVID-19
    • Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
    • Mar 28, 2020: Edwards pauses enrollments in pivotal mitral, tricuspid trials in response to hospitals' focus on COVID-19
    • Mar 04, 2020: Neovasc updates investors at SVB Leerink 9th Annual Global Healthcare Conference
    • Feb 26, 2020: Mayo Clinic reports 'remarkable growth' in 2019
    • Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
    • Feb 21, 2020: Cardiovalve's Transcatheter Tricuspid Valve System gets FDA approval
    • Feb 18, 2020: Medtronic reports third quarter financial results 2020
    • Feb 17, 2020: Hershey Medical Center becomes first in region to offer latest Edwards Sapien heart valve device
    • Feb 12, 2020: Neovasc achieves design freeze for Transfemoral Trans-septal Tiara Mitral Valve System
    • Feb 06, 2020: JenaValve raises equity financing funds for clinical programme
    • Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
    • Jan 28, 2020: Neovasc announces executive steering committee for Transfemoral Trans-septal Tiara Program
    • Jan 27, 2020: Neovasc to develop Tiara system to treat mitral valve disease
    • Jan 22, 2020: First-in-human SAVR trial begins Q1 2020
    • Jan 21, 2020: Updates on Reducer and Tiara programs will be presented at Advanced Cardiovascular Intervention 2020 meeting
    • Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
    • Jan 13, 2020: Neovasc investor update
    • Jan 09, 2020: JenaValve Transcatheter Aortic Valve Replacement (TAVR) System designated by FDA as breakthrough device
    • Jan 06, 2020: AorTech International: Heart valve development update
    • Jan 02, 2020: Neovasc announces $10 million registered direct offering priced at-themarket
    • Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health
    • Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
    • Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform
    • Nov 29, 2019: AorTech International: Unaudited interim results 2019
    • Nov 22, 2019: Early Feasibility Study (EFS) for NCSI's GATE System is approved by FDA
    • Nov 21, 2019: LivaNova to revamp heart valve division to affect 150 jobs
    • Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
    • Nov 18, 2019: MyVal transcatheter heart valve reports positive trial results
    • Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
    • Nov 07, 2019: Neovasc appoints cardiovascular industry Veteran Bill Little as Chief Operating Officer
    • Nov 07, 2019: Neovasc announces third quarter 2019 financial results
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

$4,000
$8,000
$12,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings